[Hexoprenaline tocolysis--side effects in the child?].
There were examined two groups of children, whose mother were treated with the uterine relaxant Hexoprenalin. 21 children were examined when they were three years of age, 28 children during their first week of live (internistic and neurological findings, EKG and blood-analyses). There were no signes of pathological development; all the findings were within the norm.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006594:Hexoprenaline / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D010627:Phenethylamines / Q000009:adverse effects*; D011247:Pregnancy
D010627:Phenethylamines; D006594:Hexoprenaline
Hexoprenalintokolyse--Nebenwirkungen beim Kind?